Precision polymers for next-generation
drug delivery

The pharmaceutical industry requires advanced drug delivery systems to improve therapeutic efficacy, demanding polymers with precise control and proven biocompatibility.

Synboli offers tailored solutions to meet these critical demands.

Interested? Let's Connect

A revolutionary technology

Synboli revolutionizes material science by combining cutting-edge AI with groundbreaking, patented chemistry. It accelerates the development of high-performance materials, with access to never-before-seen structures.

① High-quality data

We build vast, high-quality polymer databases for specific applications. This includes data from our proprietary chemical synthesis, enriched with trusted third-party sources.

② Accelerated AI discovery

Our proprietary AI models predict polymer properties with precision, guiding discovery directly to the ideal material for your needs.

③ Sample production

We quickly produce lab-scale samples of the most promising candidates for testing, client validation and fast iteration.

④ Industrial scale-up

We partner with experts to smoothly transition from lab innovation to industrial trials and full commercial production.

Flexible solutions

Synboli delivers technical solutions that empower leading industries to conquer both immediate and long-term material challenges.

Polymer sample synthesis and testing

Our patented chemical process allows us to create and test never-before-seen polymer structures against your specific requirements, delivering results in 2-3 months.

AI-driven polymer development

Share your requirements, and Synboli's AI platform and lab will rapidly develop new compounds. We'll iterate, starting with AI-identified structures, testing them in our lab to refine the AI. Expect optimal results in just 6-9 months.

AI-driven application domain exploration

For broader needs, we build fine-tuned AI models tailored to your portfolio. Leveraging our unique ability to generate high-quality data, these models will accelerate the development of a wide range of new polymers.

Application examples

Synboli's technology enhances key polymers for advanced drug delivery systems by optimizing acrylate polymers and PVP for mucoadhesive films, transdermal patches, and controlled-release oral excipients to improve adhesion and manage drug release. Additionally, we functionalize PEG to create more stable polymeric conjugates with longer in-vivo circulation, while precisely controlling the degradation of PLA/PLGA and PCL for predictable, long-term drug delivery from injectables and implants.